Vitamin K antagonists remain the INVICTUS standard of care for patients with rheumatic heart disease and atrial fibrillation. Liuzzo G, Patrono C. Eur Heart J 2022 Dec 17:ehac721. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liuzzo G, Patrono C. Vitamin K antagonists remain the INVICTUS standard of care for patients with rheumatic heart disease and atrial fibrillation. Eur Heart J 2022 Dec 17:ehac721. doi: 10.1093.
PMID: 36527354